O	O	O	0	13	Prostaglandin	Prostaglandin	B-NP	NN	O	3	NMOD	O
O	O	O	14	16	E2	E2	I-NP	NN	O	3	NMOD	O
O	O	O	17	19	Up	Up	I-NP	NN	O	5	SUB	O
O	O	O	19	20	-	-	O	HYPH	O	3	P	O
O	O	O	20	29	regulates	regulate	B-VP	VBZ	O	0	ROOT	O
T2	B-Entity	B-Entity	30	33	HIV	HIV	B-NP	NN	B-DNA	11	NMOD	B-DNA
T2	I-Entity	I-Entity	33	34	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T2	I-Entity	I-Entity	34	35	1	1	I-NP	CD	I-DNA	11	NMOD	I-DNA
T2	I-Entity	I-Entity	36	40	long	long	I-NP	JJ	I-DNA	11	NMOD	I-DNA
T2	I-Entity	I-Entity	41	49	terminal	terminal	I-NP	JJ	I-DNA	11	NMOD	I-DNA
T2	I-Entity	I-Entity	50	56	repeat	repeat	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	O	56	57	-	-	B-NP	HYPH	O	15	P	O
O	O	O	57	63	driven	drive	I-NP	VBN	O	15	NMOD	O
O	O	O	64	68	gene	gene	I-NP	NN	O	15	NMOD	O
O	O	O	69	77	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	O	78	80	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	81	82	T	T	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	O	83	88	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	O	89	92	via	via	B-PP	IN	O	5	VMOD	O
T3	B-Entity	B-Entity	93	95	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T3	I-Entity	I-Entity	95	96	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
T3	I-Entity	I-Entity	96	102	kappaB	kappaB	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	O	102	103	-	-	B-NP	HYPH	O	29	NMOD	O
O	O	O	103	112	dependent	dependent	I-NP	JJ	O	29	NMOD	O
O	O	O	113	116	and	and	I-NP	CC	O	29	NMOD	O
O	O	O	117	118	-	-	I-NP	HYPH	O	29	NMOD	O
O	O	O	118	129	independent	independent	I-NP	JJ	O	29	NMOD	O
O	O	O	130	139	signaling	signaling	I-NP	NN	O	29	NMOD	O
O	O	O	140	148	pathways	pathway	I-NP	NNS	O	19	PMOD	O
O	O	O	148	149	.	.	O	.	O	5	P	O

O	O	O	151	162	Replication	Replication	B-NP	NN	O	14	SUB	O
O	O	O	163	165	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	166	171	human	human	B-NP	JJ	O	6	NMOD	O
O	O	O	172	188	immunodeficiency	immunodeficiency	I-NP	NN	O	6	NMOD	O
O	O	O	189	194	virus	virus	I-NP	NN	O	6	NMOD	O
O	O	O	195	199	type	type	I-NP	NN	O	2	PMOD	O
O	O	O	199	200	-	-	B-NP	HYPH	O	8	P	O
O	O	O	200	201	1	1	I-NP	CD	O	6	NMOD	O
O	O	O	202	203	(	(	O	(	O	13	DEP	O
O	O	O	203	206	HIV	HIV	B-NP	NN	O	12	NMOD	O
O	O	O	206	207	-	-	B-NP	HYPH	O	12	P	O
O	O	O	207	208	1	1	I-NP	CD	O	13	DEP	O
O	O	O	208	209	)	)	O	)	O	6	NMOD	O
O	O	O	210	212	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	213	219	highly	highly	B-ADJP	RB	O	16	AMOD	O
O	O	O	220	229	dependent	dependent	I-ADJP	JJ	O	14	PRD	O
O	O	O	230	232	on	on	B-PP	IN	O	16	AMOD	O
O	O	O	233	236	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	237	242	state	state	I-NP	NN	O	17	PMOD	O
O	O	O	243	245	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	246	256	activation	activation	B-NP	NN	O	20	PMOD	O
O	O	O	257	259	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	260	263	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	264	272	infected	infected	I-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	O	273	278	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	O	279	282	and	and	O	CC	O	14	VMOD	O
O	O	O	283	285	is	be	B-VP	VBZ	O	14	VMOD	O
O	O	O	286	295	modulated	modulate	I-VP	VBN	O	27	VC	O
O	O	O	296	298	by	by	B-PP	IN	O	28	VMOD	O
O	O	O	299	311	interactions	interaction	B-NP	NNS	O	29	PMOD	O
O	O	O	312	319	between	between	B-PP	IN	O	30	NMOD	O
O	O	O	320	325	viral	viral	B-NP	JJ	B-protein	36	NMOD	B-protein
O	O	O	326	329	and	and	I-NP	CC	I-protein	34	AMOD	I-protein
O	O	O	330	334	host	host	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	O	335	343	cellular	cellular	I-NP	JJ	I-protein	36	NMOD	I-protein
O	O	O	344	351	factors	factor	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	O	351	352	.	.	O	.	O	14	P	O

O	O	O	353	366	Prostaglandin	Prostaglandin	B-NP	NN	O	2	NMOD	O
O	O	O	367	369	E2	E2	I-NP	NN	O	10	NMOD	O
O	O	O	370	371	(	(	O	(	O	5	DEP	O
O	O	O	371	375	PGE2	PGE2	B-NP	NN	B-protein	5	DEP	B-protein
O	O	O	375	376	)	)	O	)	O	2	NMOD	O
O	O	O	376	377	,	,	O	,	O	10	P	O
O	O	O	378	379	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	380	391	pleiotropic	pleiotropic	I-NP	JJ	B-protein	10	NMOD	B-protein
O	O	O	392	408	immunomodulatory	immunomodulatory	I-NP	JJ	I-protein	10	NMOD	I-protein
O	O	O	409	417	molecule	molecule	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	417	418	,	,	O	,	O	10	P	O
O	O	O	419	421	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	422	430	observed	observe	I-VP	VBN	O	12	VC	O
O	O	O	431	433	at	at	B-PP	IN	O	13	VMOD	O
O	O	O	434	442	elevated	elevated	B-NP	JJ	O	16	NMOD	O
O	O	O	443	449	levels	level	I-NP	NNS	O	14	PMOD	O
O	O	O	450	456	during	during	B-PP	IN	O	13	VMOD	O
O	O	O	457	460	HIV	HIV	B-NP	NN	O	21	NMOD	O
O	O	O	460	461	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	O	461	462	1	1	I-NP	CD	O	21	NMOD	O
O	O	O	463	472	infection	infection	I-NP	NN	O	17	PMOD	O
O	O	O	473	475	as	as	B-CONJP	RB	O	21	NMOD	O
O	O	O	476	480	well	well	I-CONJP	RB	O	22	DEP	O
O	O	O	481	483	as	as	I-CONJP	IN	O	22	DEP	O
O	O	O	484	490	during	during	B-PP	IN	O	22	PMOD	O
O	O	O	491	494	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	495	501	course	course	I-NP	NN	O	25	PMOD	O
O	O	O	502	504	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	505	510	other	other	B-NP	JJ	O	31	NMOD	O
O	O	O	511	521	pathogenic	pathogenic	I-NP	JJ	O	31	NMOD	O
O	O	O	522	532	infections	infection	I-NP	NNS	O	28	PMOD	O
O	O	O	532	533	.	.	O	.	O	12	P	O

O	O	O	534	536	In	In	B-PP	IN	O	30	VMOD	O
O	O	O	537	540	1G5	1G5	B-NP	NN	B-cell_line	1	PMOD	B-cell_line
O	O	O	540	541	,	,	O	,	O	30	P	O
O	O	O	542	543	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	544	550	Jurkat	Jurkat	I-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	550	551	-	-	O	HYPH	I-cell_line	10	NMOD	I-cell_line
O	O	O	551	558	derived	derive	B-NP	VBN	I-cell_line	10	NMOD	I-cell_line
O	O	O	559	560	T	T	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	561	565	cell	cell	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	566	570	line	line	I-NP	NN	I-cell_line	30	SUB	I-cell_line
O	O	O	571	577	stably	stably	B-VP	RB	O	12	VMOD	O
O	O	O	578	589	transfected	transfecte	I-VP	VBN	O	10	NMOD	O
O	O	O	590	594	with	with	B-PP	IN	O	12	VMOD	O
O	O	O	595	596	a	a	B-NP	DT	O	16	NMOD	O
T4	B-Entity	B-Entity	597	607	luciferase	luciferase	I-NP	NN	B-DNA	16	NMOD	B-DNA
T4	I-Entity	I-Entity	608	612	gene	gene	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	613	619	driven	drive	B-VP	VBN	O	16	NMOD	O
O	O	O	620	622	by	by	B-PP	IN	O	17	VMOD	O
T5	B-Entity	B-Entity	623	626	HIV	HIV	B-NP	NN	B-DNA	24	NMOD	B-DNA
T5	I-Entity	I-Entity	626	627	-	-	B-NP	HYPH	I-DNA	24	NMOD	I-DNA
T5	I-Entity	I-Entity	627	628	1	1	I-NP	CD	I-DNA	24	NMOD	I-DNA
T5	I-Entity	I-Entity	629	633	long	long	I-NP	JJ	I-DNA	24	NMOD	I-DNA
T5	I-Entity	I-Entity	634	642	terminal	terminal	I-NP	JJ	I-DNA	24	NMOD	I-DNA
T5	I-Entity	I-Entity	643	649	repeat	repeat	I-NP	NN	I-DNA	18	PMOD	I-DNA
O	O	O	650	651	(	(	O	(	O	27	DEP	O
T6	B-Entity	B-Entity	651	654	LTR	LTR	B-NP	NN	B-DNA	27	DEP	B-DNA
O	O	O	654	655	)	)	O	)	O	24	NMOD	O
O	O	O	655	656	,	,	O	,	O	30	P	O
O	O	O	657	659	we	we	B-NP	PRP	O	30	SUB	O
O	O	O	660	665	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	666	670	that	that	B-SBAR	IN	O	30	VMOD	O
O	O	O	671	675	PGE2	PGE2	B-NP	NN	O	34	SUB	O
O	O	O	676	684	markedly	markedly	B-ADVP	RB	O	34	VMOD	O
O	O	O	685	693	enhanced	enhance	B-VP	VBD	O	31	SBAR	O
T7	B-Entity	B-Entity	694	697	HIV	HIV	B-NP	NN	B-DNA	38	NMOD	B-DNA
T7	I-Entity	I-Entity	697	698	-	-	O	HYPH	I-DNA	38	P	I-DNA
T7	I-Entity	I-Entity	698	699	1	1	B-NP	CD	I-DNA	38	NMOD	I-DNA
T7	I-Entity	I-Entity	700	703	LTR	LTR	I-NP	NN	I-DNA	43	NMOD	I-DNA
O	O	O	703	704	-	-	B-NP	HYPH	O	38	P	O
O	O	O	704	712	mediated	mediate	I-NP	VBN	O	38	AMOD	O
T8	B-Entity	B-Entity	713	721	reporter	reporter	I-NP	NN	B-DNA	43	NMOD	B-DNA
T8	I-Entity	I-Entity	722	726	gene	gene	I-NP	NN	I-DNA	43	NMOD	I-DNA
O	O	O	727	735	activity	activity	I-NP	NN	O	34	OBJ	O
O	O	O	735	736	.	.	O	.	O	30	P	O

O	O	O	737	748	Experiments	Experiment	B-NP	NNS	O	2	SUB	O
O	O	O	749	753	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	754	758	been	be	I-VP	VBN	O	2	VC	O
O	O	O	759	768	conducted	conduct	I-VP	VBN	O	3	VC	O
O	O	O	769	771	to	to	I-VP	TO	O	6	VMOD	O
O	O	O	772	780	identify	identify	I-VP	VB	O	4	VMOD	O
O	O	O	781	787	second	second	B-NP	JJ	B-protein	8	NMOD	B-protein
O	O	O	788	798	messengers	messenger	I-NP	NNS	I-protein	6	OBJ	I-protein
O	O	O	799	807	involved	involve	B-VP	VBN	O	8	NMOD	O
O	O	O	808	810	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	811	815	this	this	B-NP	DT	O	12	NMOD	O
O	O	O	816	820	PGE2	PGE2	I-NP	NN	B-protein	10	PMOD	B-protein
O	O	O	820	821	-	-	B-VP	HYPH	O	12	NMOD	O
O	O	O	821	830	dependent	dependent	B-ADJP	JJ	O	13	PRD	O
O	O	O	831	833	up	up	B-ADVP	RB	O	16	VMOD	O
O	O	O	833	834	-	-	O	HYPH	O	14	P	O
O	O	O	834	844	regulating	regulate	B-VP	VBG	O	14	AMOD	O
O	O	O	845	851	effect	effect	B-NP	NN	O	17	OBJ	O
O	O	O	852	854	on	on	B-PP	IN	O	18	NMOD	O
O	O	O	855	858	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	859	869	regulatory	regulatory	I-NP	JJ	B-DNA	22	NMOD	B-DNA
O	O	O	870	877	element	element	I-NP	NN	I-DNA	19	PMOD	I-DNA
O	O	O	878	880	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	881	884	HIV	HIV	B-NP	NN	O	23	PMOD	O
O	O	O	884	885	-	-	B-NP	HYPH	O	24	P	O
O	O	O	885	886	1	1	I-NP	CD	O	24	NMOD	O
O	O	O	886	887	.	.	O	.	O	2	P	O

O	O	O	888	890	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	891	895	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	896	901	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	901	902	,	,	O	,	O	6	P	O
O	O	O	903	905	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	906	913	present	present	B-VP	VBP	O	0	ROOT	O
O	O	O	914	922	evidence	evidence	B-NP	NN	O	6	OBJ	O
O	O	O	923	933	indicating	indicate	B-VP	VBG	O	7	NMOD	O
O	O	O	934	938	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	O	939	945	signal	signal	B-NP	NN	O	12	NMOD	O
O	O	O	946	958	transduction	transduction	I-NP	NN	O	12	NMOD	O
O	O	O	959	967	pathways	pathway	I-NP	NNS	O	16	SUB	O
O	O	O	968	975	induced	induce	B-VP	VBN	O	12	NMOD	O
O	O	O	976	978	by	by	B-PP	IN	O	13	VMOD	O
O	O	O	979	983	PGE2	PGE2	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	O	984	995	necessitate	necessitate	B-VP	VBP	O	9	SBAR	O
O	O	O	996	999	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1000	1013	participation	participation	I-NP	NN	O	29	NMOD	O
O	O	O	1014	1016	of	of	B-PP	IN	O	18	NMOD	O
T9	B-Entity	B-Entity	1017	1023	cyclic	cyclic	B-NP	JJ	O	21	NMOD	O
T9	I-Entity	I-Entity	1024	1027	AMP	AMP	I-NP	NN	O	19	PMOD	O
O	O	O	1027	1028	,	,	O	,	O	29	P	O
O	O	O	1029	1036	protein	protein	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	1037	1043	kinase	kinase	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	O	1044	1045	A	A	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	1045	1046	,	,	O	,	O	29	P	O
O	O	O	1047	1050	and	and	O	CC	O	29	NMOD	O
O	O	O	1051	1054	Ca2	Ca2	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	1054	1055	+	+	B-NP	SYM	O	16	VMOD	O
O	O	O	1055	1056	.	.	O	.	O	6	P	O

O	O	O	1057	1068	Experiments	Experiment	B-NP	NNS	O	12	SUB	O
O	O	O	1069	1078	conducted	conduct	B-VP	VBN	O	1	NMOD	O
O	O	O	1079	1083	with	with	B-PP	IN	O	2	VMOD	O
O	O	O	1084	1093	different	different	B-NP	JJ	O	11	NMOD	O
T10	B-Entity	B-Entity	1094	1097	HIV	HIV	I-NP	NN	B-DNA	8	NMOD	B-DNA
T10	I-Entity	I-Entity	1097	1098	-	-	O	HYPH	I-DNA	8	P	I-DNA
T10	I-Entity	I-Entity	1098	1099	1	1	B-NP	CD	I-DNA	8	NMOD	I-DNA
T10	I-Entity	I-Entity	1100	1103	LTR	LTR	I-NP	NN	I-DNA	4	NMOD	I-DNA
T10	I-Entity	I-Entity	1103	1104	-	-	B-NP	HYPH	O	11	NMOD	O
T10	I-Entity	I-Entity	1104	1109	based	base	I-NP	VBN	O	11	NMOD	O
T10	I-Entity	I-Entity	1110	1117	vectors	vector	I-NP	NNS	O	3	PMOD	O
O	O	O	1118	1127	suggested	suggest	B-VP	VBD	O	0	ROOT	O
O	O	O	1128	1132	that	that	B-SBAR	IN	O	12	VMOD	O
O	O	O	1133	1137	PGE2	PGE2	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1137	1138	-	-	B-VP	HYPH	O	18	P	O
O	O	O	1138	1146	mediated	mediate	B-NP	VBN	O	18	NMOD	O
O	O	O	1147	1157	activation	activation	I-NP	NN	O	18	NMOD	O
O	O	O	1158	1164	effect	effect	I-NP	NN	O	24	SUB	O
O	O	O	1165	1167	on	on	B-PP	IN	O	18	NMOD	O
T12	B-Entity	B-Entity	1168	1171	HIV	HIV	B-NP	NN	O	23	NMOD	O
T12	I-Entity	I-Entity	1171	1172	-	-	B-NP	HYPH	O	23	NMOD	O
T12	I-Entity	I-Entity	1172	1173	1	1	I-NP	CD	O	23	NMOD	O
O	O	O	1174	1187	transcription	transcription	I-NP	NN	O	19	PMOD	O
O	O	O	1188	1191	was	be	B-VP	VBD	O	13	SBAR	O
O	O	O	1192	1202	transduced	transduce	I-VP	VBN	O	24	VC	O
O	O	O	1203	1206	via	via	B-PP	IN	O	25	VMOD	O
O	O	O	1207	1211	both	both	O	CC	O	37	NMOD	O
T13	B-Entity	B-Entity	1212	1214	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
T13	I-Entity	I-Entity	1214	1215	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T13	I-Entity	I-Entity	1215	1221	kappaB	kappaB	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	O	1221	1222	-	-	B-NP	HYPH	O	37	P	O
O	O	O	1222	1231	dependent	dependent	I-NP	JJ	O	37	NMOD	O
O	O	O	1232	1235	and	and	I-NP	CC	O	37	NMOD	O
O	O	O	1236	1237	-	-	I-NP	HYPH	O	37	NMOD	O
O	O	O	1237	1248	independent	independent	I-NP	JJ	O	37	NMOD	O
O	O	O	1249	1258	signaling	signaling	I-NP	NN	O	37	NMOD	O
O	O	O	1259	1267	pathways	pathway	I-NP	NNS	O	26	PMOD	O
O	O	O	1267	1268	.	.	O	.	O	12	P	O

O	O	O	1269	1272	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1273	1284	involvement	involvement	I-NP	NN	O	19	SUB	O
O	O	O	1285	1287	of	of	B-PP	IN	O	2	NMOD	O
T14	B-Entity	B-Entity	1288	1290	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T14	I-Entity	I-Entity	1290	1291	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T14	I-Entity	I-Entity	1291	1297	kappaB	kappaB	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	1298	1300	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	1301	1304	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1305	1309	PGE2	PGE2	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1309	1310	-	-	B-NP	HYPH	O	13	P	O
O	O	O	1310	1319	dependent	dependent	I-NP	JJ	O	13	NMOD	O
O	O	O	1320	1330	activating	activate	I-NP	VBG	O	13	NMOD	O
O	O	O	1331	1337	effect	effect	I-NP	NN	O	7	PMOD	O
O	O	O	1338	1340	on	on	B-PP	IN	O	13	NMOD	O
T15	B-Entity	B-Entity	1341	1344	HIV	HIV	B-NP	NN	O	18	NMOD	O
T15	I-Entity	I-Entity	1344	1345	-	-	B-NP	HYPH	O	18	NMOD	O
T15	I-Entity	I-Entity	1345	1346	1	1	I-NP	CD	O	18	NMOD	O
O	O	O	1347	1360	transcription	transcription	I-NP	NN	O	14	PMOD	O
O	O	O	1361	1364	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1365	1372	further	further	I-VP	RB	O	19	VMOD	O
O	O	O	1373	1382	confirmed	confirm	I-VP	VBN	O	19	VC	O
O	O	O	1383	1388	using	use	B-VP	VBG	O	19	VMOD	O
O	O	O	1389	1390	a	a	B-NP	DT	O	29	NMOD	O
T16	B-Entity	B-Entity	1391	1397	kappaB	kappaB	I-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	1397	1398	-	-	B-NP	HYPH	O	29	NMOD	O
O	O	O	1398	1407	regulated	regulate	I-NP	VBN	O	29	NMOD	O
O	O	O	1408	1418	luciferase	luciferase	I-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	1419	1427	encoding	encode	I-NP	VBG	O	29	NMOD	O
O	O	O	1428	1434	vector	vector	I-NP	NN	O	22	OBJ	O
O	O	O	1435	1438	and	and	B-PP	CC	O	19	VMOD	O
O	O	O	1439	1441	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	1442	1457	electrophoretic	electrophoretic	B-NP	JJ	O	35	NMOD	O
O	O	O	1458	1466	mobility	mobility	I-NP	NN	O	35	NMOD	O
O	O	O	1467	1472	shift	shift	I-NP	NN	O	35	NMOD	O
O	O	O	1473	1479	assays	assay	I-NP	NNS	O	31	PMOD	O
O	O	O	1479	1480	.	.	O	.	O	19	P	O

O	O	O	1481	1488	Results	Result	B-NP	NNS	O	14	NMOD	O
O	O	O	1489	1493	from	from	B-PP	IN	O	1	NMOD	O
O	O	O	1494	1502	Northern	Northern	B-NP	NN	O	4	NMOD	O
O	O	O	1503	1507	blot	blot	I-NP	NN	O	8	NMOD	O
O	O	O	1508	1511	and	and	O	CC	O	8	NMOD	O
O	O	O	1512	1516	flow	flow	B-NP	NN	O	8	NMOD	O
O	O	O	1517	1527	cytometric	cytometric	I-NP	JJ	O	8	NMOD	O
O	O	O	1528	1536	analyses	analysis	I-NP	NNS	O	2	PMOD	O
O	O	O	1536	1537	,	,	O	,	O	14	P	O
O	O	O	1538	1540	as	as	B-CONJP	RB	O	14	NMOD	O
O	O	O	1541	1545	well	well	I-CONJP	RB	O	10	DEP	O
O	O	O	1546	1548	as	as	I-CONJP	IN	O	10	DEP	O
O	O	O	1549	1552	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	1553	1556	use	use	I-NP	NN	O	19	SUB	O
O	O	O	1557	1559	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	1560	1561	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	1562	1571	selective	selective	I-NP	JJ	O	18	NMOD	O
O	O	O	1572	1582	antagonist	antagonist	I-NP	NN	O	15	PMOD	O
O	O	O	1583	1592	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	O	1593	1597	that	that	B-SBAR	IN	O	19	VMOD	O
O	O	O	1598	1602	PGE2	PGE2	B-NP	NN	O	22	NMOD	O
O	O	O	1603	1613	modulation	modulation	I-NP	NN	O	32	NMOD	O
O	O	O	1614	1616	of	of	B-PP	IN	O	22	NMOD	O
T17	B-Entity	B-Entity	1617	1620	HIV	HIV	B-NP	NN	B-DNA	27	NMOD	B-DNA
T17	I-Entity	I-Entity	1620	1621	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T17	I-Entity	I-Entity	1621	1622	1	1	I-NP	CD	I-DNA	27	NMOD	I-DNA
T17	I-Entity	I-Entity	1623	1626	LTR	LTR	I-NP	NN	I-DNA	23	PMOD	I-DNA
O	O	O	1626	1627	-	-	B-PP	HYPH	O	22	P	O
O	O	O	1627	1633	driven	drive	B-NP	VBN	O	32	NMOD	O
T18	B-Entity	B-Entity	1634	1642	reporter	reporter	I-NP	NN	B-DNA	32	NMOD	B-DNA
T18	I-Entity	I-Entity	1643	1647	gene	gene	I-NP	NN	I-DNA	32	NMOD	I-DNA
O	O	O	1648	1656	activity	activity	I-NP	NN	O	38	SUB	O
O	O	O	1657	1659	in	in	B-PP	IN	O	32	NMOD	O
O	O	O	1660	1667	studied	study	B-NP	VBN	O	37	NMOD	O
O	O	O	1668	1669	T	T	I-NP	NN	B-cell_type	37	NMOD	B-cell_type
O	O	O	1670	1678	lymphoid	lymphoid	I-NP	JJ	I-cell_type	37	NMOD	I-cell_type
O	O	O	1679	1684	cells	cell	I-NP	NNS	I-cell_type	33	PMOD	I-cell_type
O	O	O	1685	1687	is	be	B-VP	VBZ	O	20	SBAR	O
O	O	O	1688	1698	transduced	transduce	I-VP	VBN	O	38	VC	O
O	O	O	1699	1702	via	via	B-PP	IN	O	39	VMOD	O
O	O	O	1703	1706	the	the	B-NP	DT	O	44	NMOD	O
T1	B-Protein	B-Protein	1707	1710	EP4	EP4	I-NP	NN	B-protein	44	NMOD	B-protein
T1	I-Protein	I-Protein	1711	1719	receptor	receptor	I-NP	NN	I-protein	44	NMOD	I-protein
T1	I-Protein	I-Protein	1720	1727	subtype	subtype	I-NP	NN	O	40	PMOD	O
O	O	O	1727	1728	.	.	O	.	O	19	P	O

O	O	O	1729	1734	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1735	1742	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1743	1750	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1751	1755	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1756	1765	secretion	secretion	B-NP	NN	O	17	SUB	O
O	O	O	1766	1768	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1769	1773	PGE2	PGE2	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	O	1774	1776	by	by	B-PP	IN	O	5	NMOD	O
O	O	O	1777	1788	macrophages	macrophage	B-NP	NNS	B-cell_type	8	PMOD	B-cell_type
O	O	O	1789	1791	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	1792	1800	response	response	B-NP	NN	O	10	PMOD	O
O	O	O	1801	1803	to	to	B-PP	TO	O	11	NMOD	O
O	O	O	1804	1813	infection	infection	B-NP	NN	O	16	NMOD	O
O	O	O	1814	1816	or	or	O	CC	O	16	NMOD	O
O	O	O	1817	1829	inflammatory	inflammatory	B-NP	JJ	B-protein	16	NMOD	B-protein
O	O	O	1830	1840	activators	activator	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	O	1841	1846	could	could	B-VP	MD	O	4	SBAR	O
O	O	O	1847	1853	induce	induce	I-VP	VB	O	17	VC	O
O	O	O	1854	1863	signaling	signaling	B-NP	NN	O	20	NMOD	O
O	O	O	1864	1870	events	event	I-NP	NNS	O	18	OBJ	O
O	O	O	1871	1880	resulting	result	B-VP	VBG	O	20	NMOD	O
O	O	O	1881	1883	in	in	B-PP	IN	O	21	VMOD	O
O	O	O	1884	1894	activation	activation	B-NP	NN	O	22	PMOD	O
O	O	O	1895	1897	of	of	B-PP	IN	O	23	NMOD	O
T19	B-Entity	B-Entity	1898	1906	proviral	proviral	B-NP	JJ	B-DNA	26	NMOD	B-DNA
T19	I-Entity	I-Entity	1907	1910	DNA	DNA	I-NP	NN	I-DNA	24	PMOD	I-DNA
O	O	O	1911	1918	present	present	B-ADJP	JJ	O	26	NMOD	O
O	O	O	1919	1923	into	into	B-PP	IN	O	27	AMOD	O
O	O	O	1924	1925	T	T	B-NP	NN	B-cell_type	30	NMOD	B-cell_type
O	O	O	1926	1931	cells	cell	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	O	1932	1940	latently	latently	B-VP	RB	O	32	VMOD	O
O	O	O	1941	1949	infected	infect	I-VP	VBN	O	30	NMOD	O
O	O	O	1950	1954	with	with	B-PP	IN	O	32	VMOD	O
O	O	O	1955	1958	HIV	HIV	B-NP	NN	O	33	PMOD	O
O	O	O	1958	1959	-	-	B-NP	HYPH	O	34	P	O
O	O	O	1959	1960	1	1	I-NP	CD	O	34	NMOD	O
O	O	O	1960	1961	.	.	O	.	O	3	P	O
